ResearcherBrown UniversityNo recent work listed

Kalyan C. Mantripragada

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3362-2725; OpenAlex author ID A5071882573. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2016: 2 papers

Papers 2

FOLFOX+Nab-Paclitaxel (FOLFOX-A) for Advanced Pancreatic Cancer: A Brown University Oncology Research Group Phase I Study. Co-author DOI 10.1097/coc.0000000000000246 ↗
Optimizing initial chemotherapy for metastatic pancreatic cancer. Co-author DOI 10.2217/fon-2015-0006 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Howard P. Safran · 2 shared papers, 2016 · strength 0.18
- Paper Optimizing initial chemotherapy for metastatic pancreatic cancer. DOI 10.2217/fon-2015-0006 ↗
- Paper FOLFOX+Nab-Paclitaxel (FOLFOX-A) for Advanced Pancreatic Cancer: A Brown University Oncology Research Group Phase I Stu… DOI 10.1097/coc.0000000000000246 ↗
Kayla Rosati · 1 shared paper, 2016 · strength 0.05
- Paper FOLFOX+Nab-Paclitaxel (FOLFOX-A) for Advanced Pancreatic Cancer: A Brown University Oncology Research Group Phase I Stu… DOI 10.1097/coc.0000000000000246 ↗
Thomas J. Miner · 1 shared paper, 2016 · strength 0.05
- Paper FOLFOX+Nab-Paclitaxel (FOLFOX-A) for Advanced Pancreatic Cancer: A Brown University Oncology Research Group Phase I Stu… DOI 10.1097/coc.0000000000000246 ↗
Kimberly J. Perez · 1 shared paper, 2016 · strength 0.05
- Paper FOLFOX+Nab-Paclitaxel (FOLFOX-A) for Advanced Pancreatic Cancer: A Brown University Oncology Research Group Phase I Stu… DOI 10.1097/coc.0000000000000246 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.